Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action?
D015115:5,6-Dihydroxytryptamine / Q000494:pharmacology; D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002230:Carbidopa / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D002928:Cinanserin / Q000494:pharmacology; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D005277:Fenfluramine / Q000494:pharmacology*; D008711:Metergoline / Q000494:pharmacology; D008774:Methylphenidate / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats
D002395:Catecholamines; D008711:Metergoline; D008774:Methylphenidate; D005277:Fenfluramine; D006916:5-Hydroxytryptophan; D002928:Cinanserin; D002230:Carbidopa; D010134:Fenclonine; D015115:5,6-Dihydroxytryptamine